Oncology

Eli Lilly and Company will launch a revised version of a tool that tracks the progress of cancer over time.

A specific mark in histones speeds up repairs in cancer cells, increasing their resistance to treatment.

Top news of the day from across the health care landscape.

A novel approach looks to provide researchers with the tools to make accurate and safe predictions for cancer patients.

Ribociclib treats patients with HR+/HER2- advanced or metastatic breast cancer.

Experimental drug treats patients with HR+/HER2- advanced or metastatic breast cancer.

As symptoms of depression worsen, so too does the length of survival in lung cancer patients, according to a study published in the Journal of Clinical Oncology.

Fission yeast is a low cost and fast system that can improve the cancer drug discovery process.

Top news of the day from across the health care landscape.

A drug used to treat kidney cancer could be effective fighting several types of the disease.

Only 58% of breast cancer survivors received follow-up mammograms in 2007.

Top news of the week in oncology and cancer drug development.

Researchers found a low-cost approach to examine individual cancer cells, which could lead to a breakthrough in treatments.

Debiopharm International joins the Merck-Pfizer alliance for non-small cell lung cancer treatment research.

A nonsteroid anti-inflammatory drug used to treat common colds blocks bladder cancer cells from spreading in mice.

Top news of the day from across the health care landscape.

Positive results in the KEYNOTE-045 clinical trial of Keytruda showed improved overall survival.

The widely publicized untested oncology drug scandal could lead to better clinical practice.

Catalent Pharma Solutions and Moderna Therapeutics supports manufacturing of cancer vaccines.

Tennessee pharmacist admits to falsifying prior authorizations, medical lab reports, and drug test results for at least 51 hepatitis C patients prescribed Sovaldi, Harvoni, Viekira Pak, and Daklinza.

Pharmacists should keep tabs on the mental state of patients treated for lung cancer.

First-line pembrolizumab in addition to standard chemotherapy improved response rates and survival in patients with advanced non-small cell lung cancer.

Androgen deprivation therapy may increase the risk of developing dementia.

High-risk soft tissue sarcoma patients given anthracycline plus ifosfamide were found to have significant increases in survival.

Top news of the day from across the health care landscape.

Superior progression-free survival achieved with cabozantinib over sunitinib in patients with metastatic renal cell carcinoma.

An injection of flufenamic acid prevented invasive cancer cell activities in mouse models.

Supplements given to prostate cancer patients following radiotherapy could harm disease outcomes.